Patent MarketPlace: Health and Beauty Products (HBA) Patents for Sale

Woman with facial irritation removing a face mask.Replacement for Irritating Face Masks (Lin): International Patent Portfolio

COVID-19 changed the world. For the first time in this generation, wearing a mask to prevent the spread of a disease became commonplace. However, traditional full-face masks create a major compromise between health protection and daily life. A face mask makes eating or drinking impossible. In high-risk environments – long-haul flights, crowded restaurants, school cafeterias, corporate breakrooms, or emergency camps – users must remove their mask to eat, leaving them fully exposed to airborne pathogens during meals. Conventional masks trap moisture and hot exhaled air, causing discomfort in warm climates and continuously fogging eyeglasses. Muffled voices and hidden facial expressions hinder everyday interaction.

This international patent portfolio introduces the first new thinking in face masks since the Spanish flu pandemic of 1918 – an ergonomic nasal mask that isolates protection exclusively to the point of inhalation via a specialized nasal septum retainer. The device provides 24/7 continuous protection, but it leaves the mouth completely free so users can eat, drink, talk, and work without removing their inhalation protection. It is cool and unobtrusive. There is no heat buildup, facial sweating, skin irritation, or eyeglass fogging. A device based on this portfolio can be put into production very quickly, and devices can be produced in high volumes with low-cost manufacturing, packaging, and transportation.

Patent Portfolio

This portfolio – or selected patents from the portfolio – will enable any medical supplies manufacturer to go to market very quickly with next-generation nose mask and nasal guard.

Laminaria japonica kelp.Inhibiting Cancer Growth and Relieving Pain (Infinitum): U.S. Patent No. 12,364,725 and U.S. Patent Application 20260137743

Laminaria japonica, Undaria pinnatifida, Palmaria palmata, Fucus vesiculosus, Grifola frondosa, Ganoderma lucidum, Hericium erinaceus, Cordyceps sinensis, and Euterpe oleracea are not typically known as having medicinal qualities. For example, Laminaria japonica is a marine kelp and is the flavor foundation for Japanese soup stock! The inventor of this patent and patent application has discovered incredible medical benefits from these all-natural ingredients.

The first is a combination of naturally derived compounds for inhibiting cancer growth, with additional disclosure directed to antiviral applications. The patent includes experimental evidence evaluating cell viability across multiple cancer cell lines, including glioblastoma, melanoma, lung carcinoma, and prostate carcinoma. The second formulation covers compositions and methods directed toward reducing recurring, chronic, acute, and migraine pain using defined combinations of naturally derived compounds, creating a potential platform for non-opioid pain-management applications. This patent and patent application represent an emerging therapeutic IP platform spanning oncology, antiviral applications, and non-opioid pain management, with potential relevance to pharmaceutical, specialty pharmaceutical, consumer healthcare, integrative medicine, and other therapeutic-development companies.

U.S. Patent No. 12,364,725 for “Methods of inhibiting cancer growth and inhibiting viral infections” and U.S. Patent Application 20260137743 for “Methods of relieving pain” could be used by any nutraceutical product manufacturer to introduce two exciting, totally safe and natural remedies.

Woman applying antimicrobial hand sanitizer.Commercial-Ready Antimicrobial Product Based on CBD with Broader Potential (Pharmotech): International Patent Portfolio

While the acute phase of the Covid pandemic has passed, the demand for advanced hand hygiene remains critical. Current alcohol-based solutions fail to provide residual protection and leave dry, cracked skin with regular use. This portfolio solves both issues with a unique formulation that delivers immediate kill rates while creating an “invisible shield.” It is the only 100% natural product capable of keeping hands moisturized while also providing continuous protection for up to three hours after a single application. It provides continuous protection from resistant bacteria, fungi, and viruses, including pseudomonas aeruginosa, Clostridioides difficile, methicillin-resistant staphylococcus aureus, and E. coli. There is zero transdermal absorption of the 100% pure CBD in the formulation, guaranteeing a THC-free composition fully compliant with the U.S. Farm Bill, removing regulatory friction for U.S. distribution.

Patent Portfolio

The portfolio includes U.S., European, Chinese, Canadian, Australian, Russian, Mexican, Spanish, and Chilean patents and patent applications. This patent portfolio – or selected patents from the portfolio – may be used to instantly launch a family of derivative products such as premium cosmeceuticals, professional toothpaste/mouthwash, patches, plasters, post-tattoo cream, post-operative cream, and wound dressings, plus many veterinary products.

Improved Formulation Eye Drops (Platform Ophthalmic): U.S. Patent Nos. 11,951,123 and 12,397,017

Nearly 16.4 million Americans have dry eye according to the National Eye Institute, and most use over-the-counter (OTC) dry eye drops to remedy irritation, burning, and the dry scratchy feeling that comes with itchy eyes. The problem is that most of the OTC eye drops currently on the market only treat the symptoms of dry eye.

This patent family introduces a line of dry eye drops that actually improves eye health! Composed of several vital natural ingredients, eye drops based on this patent family would NOT require a prescription. The active ingredient in the formulation is povidone with hyaluronic acid as an inactive ingredient – a formulation that produces superior lubricity as well as enhanced shear thinning viscosity and wettability. As an OTC treatment for dry eyes, a formulation based on this patent family would produce less blurring in vision, a reduction in the feeling of abrasion during blinks, and a general improvement in eye comfort.

U.S. Patent Nos. 11,951,123 and 12,397,017 for “Fortified nutritional lubricating drops for dry eye disease” would provide any nutraceutical drug manufacturer with a formulation for a line of highly effective eye drops.

Powdered Botanical Extract Preparation (Fong): U.S. Patent Application 20210393719

Lipophilic compounds such as cannabinoids are substances that are "fat-loving" molecules that dissolve in fats, oils, and other non-polar solvents such as steroids, fatty acids, and certain vitamins. These compounds are vital in drug delivery because they can readily cross cell membranes, but formulating them into stable, bioavailable products has been a challenge – until now.

This patent application introduces a novel technology platform for producing solid self-emulsifying drug delivery systems (sSEDDs) through a one-pot powder-forming process. The technology converts lipophilic compounds such as cannabinoids, active pharmaceutical ingredients, and antioxidants into a stable, water-dispersible powder. These water-dispersible powders enhance oral, dermal, and mucosal bioavailability and provide dose consistency and stability. The technology has broad applicability across pharmaceuticals, nutraceuticals, cosmetics, and dermatology – including products for treating eczema and psoriasis. Its superior dermal penetration also makes it suitable for anti-aging products, facial creams, body lotions, and haircare. They even have applications in food supplements and CBD wellness formulations.

The current patent claims protect not only cannabinoid formulations, but – most importantly – the underlying novel process for producing sSEDDs and establishing a versatile platform. The technology offers extendable IP coverage for other botanical and lipophilic compounds through potential continuation or derivative filings, providing strong opportunities for expansion across multiple product categories.

U.S. Patent Application 20210393719 for a “Powdered botanical extract preparations and formulations thereof” provides manufacturers with a versatile, scalable platform for developing next-generation, self-emulsifying, water-dispersible formulations of lipid-based actives – enabling enhanced efficacy and innovation across pharmaceuticals, nutraceuticals, cosmetics, and wellness products.

Non-Alcohol Hand Sanitizer (Safehands): U.S. Patent No. 9,693,564

In a post-Covid world, it has become increasingly more common for us to sanitize our hands on a regular basis – when we enter a store, office, restaurant, or other facility, before we eat, or when we come in contact with children, the elderly, or someone whose immunity may be compromised. The problem is that all the hand sanitizers currently on the market are alcohol-based. Alcohol kills germs by stripping away the skin's protective barrier of oils on your hands, leaving hands dried and cracked, and susceptible to germs entering your body. Alcohol-based sanitizers result in alcohol in the blood and urine after multiple uses. Compounding the side effects is that alcohol is highly flammable and toxic.

Surely there must be a hand sanitizer that is NOT alcohol-based, but still kills germs quickly and efficiently. There is! This patent covers the FDA-allowed benzalkonium chloride (BAC) that is active in this formulation. The result is an FDA-allowed hand sanitizer that is affordable, practical, and effective – but contains NO alcohol. The patented formula combines benzalkonium chloride (BAC) with two inactive ingredients to effectively kill more germs than an alcohol-based sanitizer, but without all the negative aspects of alcohol. After using this hand sanitizer, your hands are smooth and soft, not dried and cracked!

U.S. Patent No. 9,693,564 for a “Water based antimicrobial composition using benzalkonium chloride and cocamidopropyl PG-dimonium chloride phosphate” would enable any current supplier of hand sanitizer to add a highly effective – but alcohol-free – sanitizer to its product line.

Do-It-Yourself Acupressure Facial (Touch + Glow): U.S. Patent Nos. 12,023,298 and 12,029,702

Acupuncture has been around for over two thousand years and has been a proven treatment for numerous ailments and conditions. One very effective use for acupuncture is to tighten the skin, removing and softening wrinkles to create a fresher, younger, look and feel. Wouldn’t it be great if we could have the benefit of acupuncture without all those needles? With acupressure we can.

This patent family creates a non-invasive, therapeutic wand with point prescription acupressure protocol. The user follows the instructions by touching the tip of the wand to specific points on the face. The tip of the wand vibrates while it also produces a magnetic field, and the combination of the two tightens the skin as the wand passes over it, significantly softening wrinkles. This simple process is easy, painless, safe, and highly effective. The wand includes a printed circuit board and timer that guides the user through the massage.

Not only can U.S. Patent Nos. 12,023,298 and 12,029,702 for a “Therapeutic wand system, kit, and method” be used for a highly effective acupressure facial, its versatility gives the owner the flexibility to create therapeutic acupressure point remedies for pain management, sleep disturbances, stress, and other ailments. This patent family would be a strategic acquisition for any manufacturer in the healthcare or beauty industry.

Patent Brokerage Prospectus: Contact [email protected] to receive an analysis of each portfolio that includes:

We offer patents in these technologies: